Professional Documents
Culture Documents
1 APPROVAL
2 INTRODUCTION
3 VALIDATION POLICY
4 OBJECTIVE
5 SCOPE
6 VALIDATION RESPONSIBILITIES
10 ACCEPTANCE CRITERIA
14 VALIDATION SCHEDULE
15 ANNEXURE
HMA MEDICAL LTD Page 3 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
16 GLOSSARY
INITIATED BY:
Production Manager
Maintenance Manager
CHECKED BY:
APPROVED BY:
General Manager
AUTHORIZED BY:
HMA Medical Limited is an indigenous, state of the art, medical devices manufacturing company
which uses specialized automated manufacturing equipment for the production of syringes, and
disposable hypodermic needle set of various pack sizes under the trademark “Deleject”. It is
situated at Plot 9b, Block 4, Transit Camp Road, Lubcon Avenue, Ilorin Kwara state, Nigeria.
The facility was designed in the year 2017 to meet national regulatory and cGMP requirements.
The manufacturing facility is supported by Maintenance/Engineering, Warehouse, and Quality
Assurance departments with all these departments covered under the relevant validation activities.
The Validation Master Plan is a dynamic document which provides complete overview of the
validation program.
It describes the overall objective, intention and approach for establishing performance adequacy of
equipment, utilities, processes and systems.
It identifies the scope of validation, applicable validation protocol reports, procedures and
frequency of validations.
3.1 The organization HMA Medical Limited is committed to the concept of validation and all
processes, facilities, equipment, machines, instruments, control systems, utilities, and analytical
methods are put through appropriate qualification and validation cycles before being accepted
for use. Performance qualification shall be carried out for all critical equipment used for
manufacturing, engineering and quality control.
3.2 All systems are subject to ongoing validation to evaluate the impact of changes in process,
systems, environment, equipment directly or indirectly on the product.
3.3 Three validation studies are carried out as per protocol prepared by nominated team members
from various departments
3.4 For certain equipment/instruments in case-by-case basis, the manufacturer’s qualification
document shall also be taken as inputs for qualification activities this includes pre delivery,
inspection and FAT.
4.1 This Validation Master Plan is a document, which describes HMA Medical Limited intentions
and the methods which are related to validation of the equipment, instruments, systems, utilities,
facilities, materials, analytical methods and processes.
4.2 Validation Program is designed to demonstrate that the facility for the production up to the final
stage of production of different pack sizes of finished product and intermediate components is
capable of meeting the process parameters in a repeatable and controllable manner.
4.3 Validation Master Plan ensure that validation activities are carried out as per respective protocols
and after completion will determine whether the equipment, systems, process and methods,
Meets the specification of its design
Suitable for its intended applications
Conform to the basic cGMP design criteria
HMA MEDICAL LTD Page 8 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
5.3 Validation Master Plan applies methodology of validation program to the following,
Facilities
Equipments/ Instruments/ System (Qualification)
Utilities (e.g. HVAC, Water system and Compressed Air)
Control Systems (e.g. Computer hardware and software)
HMA MEDICAL LTD Page 9 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Manufacturing processes
Cleaning processes
Analytical methods
Environmental (Physical & Microbiological)
Personnel (e.g. Analysts, checkers on inspection or packing line)
Revalidation or Requalification
VALIDATION MASTER PLAN DATE: JUNE, 2023
6.0 VALIDATION RESPONSIBILITIES
6.1 Validation Team Constitution
6.1.1 The overall validation process is coordinated by a team, which is a working group comprising of
qualified personnel as required for the specific validation activities.
6.1.2 The validation team is made up of representatives from the following areas:
Quality Assurance
Production
Maintenance
Quality control
6.1.3 Validation team is responsible for:
Preparation of Validation Master Plan
Determination of the equipment, instruments, systems, facilities and utilities to be
validated
Preparation of validation and qualification protocols
Execution of the validation and qualification protocols
Determining the suitability of the established protocol to qualify a system
Approving all validation protocols and report each validation from respective functional
department heads
Reviewing each protocol and reports content to assure compliance with current
regulations and guidelines
HMA MEDICAL LTD Page 10 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Verifying the adequacy of the tests used for the verification of the system as established
by the validation protocols
Determine the extent of revalidation necessity in case of changes in a validated system
Document control
6.1.4 Other personnel will be utilised, as necessary, by the members of the validation team to assist in
the assessment of the special equipment, system, utilities where their area of expertise will
facilitate the development and execution and assure the quality of the validation efforts
6.1.5 Individual responsibilities of different departments are as follows:
6.1.5.1 Production: it is responsible for,
Describing the production process in collaboration with Quality Assurance
Preparation of the batch records in collaboration with Quality Assurance
Transferring the processes to the production facility in collaboration with Quality
Assurance
Providing all current and approved standard operating procedures to be used as part of
manufacturing process
Providing personnel and materials as required for the execution of validation
protocols, equipment trials and process trials.
Training of all manufacturing personnel in technical, validation and GMP aspects
Sampling and execution of process controls
Preparing reports on any deviation that occurs during process
Participating in preparation of draft validation protocols
Executing DQ, IQ, OQ, and PQ with validation team members as per validation
protocols
Tracking for validation requirements
Operating and maintaining plant, facilities, equipment, support systems and the
specific manufacturing process within its design limits.
6.1.5.2 Maintenance: it is responsible for,
HMA MEDICAL LTD Page 11 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Instrument list
Building
Maintenance requirements
Spare part list
Calibration requirements and procedures
Equipment design, installation and system construction procedures
Operational recommendations
Coordination of calibration activities for all critical instruments as defined by the
validation team
Participating in preparation of draft validation protocols
Executing DQ, IQ, and OQ tasks and assisting in the execution
Preparing and maintaining calibration records for all critical instruments
Executing the installation and maintenance of production facilities and laboratories
Training of all engineering personnel in technical, validation and GMP/GEP aspects
NOTE: Critical instruments are those which have direct impact on the product quality, i.e.,
instruments which measure, monitor, or control manufacturing, processing and testing
parameters.
6.1.5.3
Quality Control: it is responsible for,
Participating in preparation of draft validation protocols
Training of all Quality Control personnel in technical, validation and GMP/GLP aspects
Testing of validation samples as per validation protocols and specifications.
Preparing laboratory reports by collecting data and verified summaries of findings and
conclusions
Ensuring that the laboratory systems, instruments, devices and equipment to be used in
6.1.5.4 the course of validation studies have been qualified, validated and calibrated
HMA MEDICAL LTD Page 12 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
reinforcements and rafters, aluminium roofing, concrete plaster, and non-flaking paint wall
finishing, metal doors and aluminium frame glass panel window.
7.1.5 The clean areas are enclosed within the manufacturing building with pre-fabricated cork
filled/insulated aluminium wall and ceiling panels, pre-fabricated cork filled/insulated
aluminium door panels, non-laminated hard clear glass fittings, sealed window panels, high
quality PVC plastic finished concrete flooring, epoxy flooring in some areas like the needle
assembly, all manufacturing areas and corridors of the new extension, Injection Moulding.
7.1.6 Air locks and pass boxes are also installed in the new extension.
The return air risers of the HVAC system are concealed within the wall to avoid recesses, the
7.2 terminal filter and lighting feature are recess type and ceiling mounted.
Description of Products
7.3 As per attached Annexure
Description of Process flow
7.4 As per attached Annexure
List of equipment
As per attached Annexure
8.0 VALIDATION PROGRAM AND SUPPORTING SYSTEMS
8.1 Fundamentals of Validation Program
8.1.1 The validation programme shall be divided into five phases as follows:
Phase I- Preparation and Approval of the Validation Master Plan
Phase II - Preparation and Approval of the Validation Protocol
Phase III- Execution of Validation protocols, tests laid down in Validation Protocols and
data collection.
Phase IV – Preparation of Validation Report, Compilation of data collected during
Validation, review, recommendations and Approval of validation Report.
Document shall be kept under the custody of the Quality Assurance.
Phase V - On going evaluation, review, Change Control, Deviations and Revalidation.
HMA MEDICAL LTD Page 14 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
8.1.2 The Validation Master Plan (VMP) shall be prepared by the Validation Executive.
The document shall be checked by the Heads of all Functional area.
8.1.3 The document shall be approved by the Quality Assurance Manager and General Manager and
authorized by the Group Managing Director.
8.1.4 There shall be separate protocols for DQ, IQ, OQ, PQ (where ever applicable), Environmental
Control, Analytical method validation, facility, Utility, Process Validation, and Cleaning
Validation etc. All the protocols shall be numbered as per SOP for the numbering of reports and
protocols.
8.1.5 The protocols shall consist of the objective, scope, responsibilities, procedures for conducting
the tests for validation. The results observed during the validation studies, summary, conclusion
and final approval shall be included in the reports.
8.1.6 Validation Executive and Concerned department Executive shall initiate the Validation
Protocols. Concerned HOD and HOD of production, Engineering/Maintenance shall
check/verify, Quality Assurance Manager and General Manager shall Approve while the Group
Managing Director finally authorize the validation protocol.
8.1.7 The approved Master Copies of protocol shall be kept in the custody of the Quality Assurance
Manager. During execution of validation protocol, validation report shall be prepared as par
protocol and attach the collected data of the same to the reports.
8.1.8 Summary and Conclusion Report and Approval
After the execution of the protocols, a validation task report shall be reviewed,
summarize, concluded and recommendations made by the team carrying out the
validation activity and approved by the involved team members.
8.2 Supporting systems for validation program:
9.1 Definition:
9.1.1 The collection and evaluation of data, beginning at the process development stage and
continuing through the production phase, which ensures that the facility, equipment, equipment,
manufacturing process, control systems utilities and personnel and materials are capable of
achieving the intended results on a consistent and continuous basis and thus is capable of
consistently producing a product that meets the established products specification.
9.1.2 Validation is documented evidence which can confirm predetermined critical parameters
The supplied materials shall be checked /analysed with reference to the in-house specifications.
9.2.3.3
9.2.4.1 The objective of the computer system validation is to demonstrate that the computer
system performs (Create, modify, archive and retrieve) as it is supposed to
This shall be based on following:
Specification for software depending on intended use
Computer and manual modes of data validation giving similar results.
Accessibility, durability and accuracy of stored data
Levels of authority for data entry and change.
Accuracy and reliability of data entered.
Security system to ensure any alteration or pilferage of data.
To control the equipment/ instrument/ system, computer hardware and software systems
used as a part of equipment or instrument or system must be validated. Design qualification,
Installation qualification and operational qualification shall be executed prior to
performance qualification of associated equipment/ instrument/ system.
To expedite the process of validation, the computer system validation shall be done as a part
of equipment/ instrument/ system validation.
The following are the contents for computer hardware and software validation:
1. Detail description of control system
Control panel
Power supplies
Temperature sensor (Wherever applicable)
Humidity sensors (Wherever applicable)
Smoke detectors (Wherever applicable)
CPU
Location
Manufacturer
Model
Processor
Capacity
Disk type
HMA MEDICAL LTD Page 18 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Verification that the controlled devices for the system as per approved drawings,
specifications and authorised change orders.
Verification that all the controlled devices have been installed and tagged as per ,
o Manufacturer
o Model
o Location
o Description
o Function
o Calibration date
o ID number
Verification that all the wiring done as per specifications. Execution of point to point
verification between the control panel. Confirm the correct identification of wires
and / or air control lines.
Evaluate the controlled functions for their potential effect on the quality strength,
purity and safety of the final product.
Equipment validation (Qualification):
1. Design Qualification
2. Installation Qualification
3. Operational Qualification
4. Performance Qualification
3.5 Maintenance
4.0 Life Cycle
4.1Prefered vender list
4.2Development
4.3Testing
4.4 Delivery
4.5 Support
5.0 Glossary
6.0 References
7.0 Approval
Note: Numbering system as per SOP of User requirement specification
Process validation:
Process validation is established documented evidence which provides a high degree of
assurance that a specific process will consistently produce a product , meeting its
predetermined specifications and quality characteristics.
If a new product is duplicasy of the existing product then its validation shall be bracketed
with the existing product.
The purpose of process validation is to demonstrate the reliability and reproducibility of
manufacturing process, within established parameters and to assure batch uniformity and
integrity of drug products. A process validation program shall establish a documented
HMA MEDICAL LTD Page 23 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
1. Prospective validation:
Prospective Validation shall be carried out on the small scale or R & D batches during
development stage.
These validations were carried out to identify the processing steps, equipment settings and
process timings, which can prove to be critical in overall impact of product quality. All
these steps, equipment setting and process timing are evaluated to finalise the setting
parameter. Limits of all critical parameters shall put tentatively.
This draft form of study can lead towards the finalisation of Batch Manufacturing Record /
Batch Packing Record for large scale batches.
The prospective validation shall take care of following:
1. Process description
2. Investigation summary of critical processing steps
3. Finished product release specification
4. Calibration of equipment
5. Appropriate analytical methods
6. Proposed in process control with acceptance criteria
HMA MEDICAL LTD Page 24 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
7. Sampling plan
8. Method for recording and evaluating results and responsibilities.
2. Concurrent validation:
This validation comprises of determination and evaluation of process parameters
applicable from scale up to large scale batches.
Process validation for establishing the predetermined limits of all critical parameters
by conducting three consecutive commercial or large scale batches.
Validation carried out during routine production or products manufacturing for sale.
The tests are finalised based on evaluation of the results of these batches. These
batches were monitored for stability and quality trends.
Matrix approach can be applied to process validation. The matrix approach means that
a plan to conduct process validation on different strength of same product,
manufactured by the same process and similar type of equipment. e.g. validation on
one strength (preferably smallest) as a representative amongst the multiple strength of
the same product. This approach should be in accordance with cGMP and should
demonstrate that the process is consistent for all the strength.
Note: The batches will not be dispatched unless and until the analysis of the validation sample is
completed.
3. Retrospective validation:
Historical trending of all critical parameters obtained from analytical results and / or
IPQC results observed after testing of physical, chemical and microbiological parameters
of product manufactured by same process. To ensure that all the parameters shall be in
the limit and in uniform range.
Retrospective validation shall done yearly of products or batches manufactured in
previous year.
Minimum first 20 batches shall consider for retrospective validation. If less than 20
batches were manufactured in one year then batches of previous years were consider for
trending.
HMA MEDICAL LTD Page 25 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
4. Revalidation:
Periodic revalidation: This type of revalidation shall be done on periodic basis as per
specified frequency. The revalidation shall be governed by the Change Control
procedure.
Revalidation after any change: All validated equipment, systems, processes, products etc.
shall be continuously monitored for any change, to be considered for revalidation of the
same.
Revalidation / Requalification [Verification of validation] shall be considered in the case
of :
Equipment / Instruments / System:
1) Substitution of existing equipment with a new equipment /instrument/System.
2) Change of site /location of the equipment / instrument / System from qualified existing
place to other place.
3) Any major modification in the existing equipment / instrument /System since purchase
which can have an adverse effect on the quality and efficacy of the finished product.
Manufacturing Process:
A change in the validated manufacturing process that has an effect on the quality and
efficacy of the finished product, which includes a change in the following:
1) Master formula or manufacturing process.
2) Raw Materials
3) Equipment
4) Batch Size
5) Change in manufacturing site or location.
1. Cleaning validation:
Definition:
· Validation of the process by which the equipments are cleaned is called as cleaning
validation.
HMA MEDICAL LTD Page 26 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Objective:
Cleaning validation is an important mechanism to protect the pharmaceutical products
from cross contamination. A pharmaceutical product can be contaminated by previous
product residues, traces of cleaning agent, micro-organisms or any foreign particle as
borne particles, dust, raw materials etc.
This should be performed to provide a documented evidence that the procedure being
followed for cleaning of equipment and accessories is effective and removes residues of
previous batch / product up to a predetermined acceptance level, using a well defined
protocol and acceptance criteria.
For equipments which are not product specific, cleaning procedure for such equipment
should be able to ensure that it can consistently remove residues to the predetermined
level.
Procedure:
There are two methods employed for sampling during cleaning validation. These are Rinse
and Swab method. Rinse method will be applicable when swabs are not practically
possible.
Cleaning procedures for products and processes, which are very similar are do not need to
be individually validated. Representative of similar range can be selected to justify the
validation programme, which addresses the critical issues relating to selected products and
processes.
A single validation study under consideration of the “worst case” can be carried out on
the basis of the maximum strength, potency, solubility and LD50. The cleaning validation
can be evaluated,
1. For highest strength product in multi strength products or all products.
2. For highest potency product in all products.
3. For least solubility in common cleaning solvent i.e. Water.
This “worst case” term can also be referred as “bracketing”. And such approach is called as
matrix approach.
HMA MEDICAL LTD Page 27 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Three cleaning validations exercise shall be performed and shown to be successful in order
to prove that the method is validated.
The documentation of cleaning validation shall include validation protocol, cleaning
procedures, sampling plans, surface area calculations, testing procedures and executed
record of the cleaning event, a record of the sampling and testing events and a validation
report which contains clear conclusions against acceptance criteria.
This validation shall covers sanitation, microbiology as well as removal of external
agents like detergents, using sampling techniques capable of detecting and measuring to
very low levels wherever applicable.
There are two criteria’s for the cleaning validation, one is dose criteria and second is 10
PPM criteria.
Validated analytical methods used for cleaning validation shall have sensitivity to detect
residues or contaminant of previous product. The detection limit for each analytical
method should be sufficiently sensitive to detect the established acceptance level of
residues or the contaminant
Equipment surface area calculation:
1. The product contact surface area for each equipmenshall be calculated by
theoretically breaking down the equipment in to basic geometric shapes
[cylindrical, cubical, cone, rectangle etc.] and then apply to relevant area
calculation formulae.
2. Amount of contaminant, mix from previous product to next product, depend on
the common surface area of equipment used for both previous and next product.
Responsibility:
Quality Assurance:
Generation of validation protocol
Sampling during validation
Review and compilation of validation data & certification
Production:
HMA MEDICAL LTD Page 28 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Water system is one of the utility which have directly or indirectly impact on
products. There are mainly three types of water system as follows,
Raw water system [Potable water]
DM water system [Deionised water]
Purified water system
New water system shall be established and use for regular purpose after one year
validation study includes the results of chemical and microbiological quality of the
water.
o For qualifying the DM water system & purified water system, Chemical and
Microbiological Test shall be conduct mentioned as follows.
o Temperature, PH, Conductivity, Colour, Total hardness, Total dissolved solids,
Turbidity, Alkalinity and presence of ions or minerals, Microbial counts, pyrogens
and endotoxins. Test method for each tests shall be mentioned in the protocol.
o Location of sampling points shall be done as per specified in Validation protocol or as
per SOP.
o Frequency for all above mentioned tests shall be mentioned in the individual
validation protocol.
o Validation of water system shall divide in to three different phases as follows.
Frequency of sampling, number of samples taken and no. of sampling locations are
reduces from phase I level to next phase level
Phase – I –
Phase – II –
Phase – III –
Following acceptance criteria:
1. Raw water circulation and its storage shall be requalified if microbial load is
if,more than 500 CFU / ml and chemical water quality shall confirms to In-house
HMA MEDICAL LTD Page 30 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
standards.
2. Demineralised water circulation and its storage shall be qualified if microbial load
is if, more than 100 CFU / ml and chemical water quality shall confirms to In-
house standards.
3. Purified water circulation and its storage shall be qualified if microbial load is
if,more than 10 CFU / ml and chemical water quality shall confirms to In-house
standards.
4. For acceptance criteria of chemical and microbiological tests of purified
water,USP – 41 [NF – 36] shall be refer.
Sanitization of purified water system shall be done after 15 days
Water system shall be revalidate if there is any major change, replacement or
modification in existing system. It shall be periodically revalidate or verified once
in a year on the basis of monthly, weekly or daily testing data as per scheduled
trend.
4. Compressed air system:-
Compressed air system is one of the utility which have directly or indirectly impact on
the quality of the product.
Sampling locations shall be mentioned in the validation protocol. Sampling method of
Compressed Air shall be carried out as per respective Standard Operating Procedure.
Following test shall conduct to qualify compressed air system. Limits or Acceptance
criteria for each tests shall defined in the validation protocol.
1. Water vapour: Dew point and moisture content in air shall identify.
1.1 Pressure Dew point : 0 to + 3° c.
1.2 Atmospheric Dew point : – 15 to – 20° c.
2. Compressed Air must be oil free so during the course of generation it
does not comes in contact with Oil.
3. Hydrocarbons should be less than 5 mg / m3.
4. Micro organisms should be less than 3 CFU/ m3.
HMA MEDICAL LTD Page 31 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
5. Particulate matter such as fibres and metal particles should be NMT 100 particles of 0.5
mper cubic feet of air.
6. Compressed air system should meet the class 100 requirement.
Frequency of different tests of different frequency should be specify in to the validation
protocol.
Data of chemical and microbiological analysis collected monthly or quarterly shall be
reviewed and trend shall be prepared for year.
Based on the trend data of the year summary report shall be prepared and shall be
approved at unit levels.
Compressed Air System shall be revalidate if there is any major change, replacement or
modification in existing system. It shall be periodically revalidate or verified once in a
year on the basis of monthly and yearly testing data as per scheduled trend.
Note: During validation program of above described utilities some tests were conducted by
external party and some tests were in-house, specified in validation protocol.
11.4 This shall be based on the comprehensive understanding of the product, process, system and
components. Where possible this assessment of impact shall be defined in the user requirement
specification & process validation.
11.5 Risk and issue management strategy:-
Sources of risks: Risk sources are broadly categorized into,
New project
Introduction of new equipments in to the existing facility
Changes in the existing facility or utility or equipments
Introduction of new product
Change in the approved vendor.
11.6 Method of Risk identification and Evaluation:
Impact assessment: The risk is identified and categorized in to impact and no impact.
Identify the system
Develop system boundaries
Does the system have an direct impact on product quality
Is it linked with direct Direct impact
impact system
No impact system Indirect Impact Develop supporting rational
11.7 Based on the findings, if the impact of the risk is direct or indirect one, then the extent of
validation is decided i.e. whether it requires a process, equipment, analytical method, cleaning
process or vendor qualification.
11.9 When a new product is introduced in to the existing system, the risk is assessed by using
matrix vs. does form which is evaluated in the product development plan for the process
validation and cleaning validation.
11.10 Impact assessment: The applicability of any thing of the following criteria was taken as an
indication that the system has direct impact or indirect impact on the product. Systems such
provides Utility which has direct contact with the product are compressed air, purified water,
Pure stem and HVAC system
Name of System /
Description Equipment / Direct impact Indirect impact Remark
Instrument
Area — Y — —
HVAC System Y — —
Compressed air Y — —
Potable water N Y —
Pure steam Y Y —
All equipments
used in the
Equipments Y — —
manufacturing
processes
All equipments N Y —
or machineries
HMA MEDICAL LTD Page 34 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
12.1 The Standard Operating Procedures relevant to the equipment, process,and analytical
methods shall be available at individual site.
14.1 The Validation for equipment, instruments, systems and processes which requires to be
periodically revalidated at defined frequency as per individual validation protocol within ± 1
month of the due date.
15.0 GLOSSARY
1. Acceptance criteria:
The product, equipment, and /or process specifications and limits, such as acceptable
quality level and unacceptable quality level, that is necessary for making a decision to
accept or reject.
2. Calibration:
Demonstrating that a measuring device produces results within specified limits of those
HMA MEDICAL LTD Page 35 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
process failure when compared to ideal conditions. Such conditions do not necessarily induce
product or process failure.
18. Critical Part:
Part of an equipment which can affect the quality of product directly is known as critical part.
Retrospective Validation: -
Retrospective Validation shall be used for facilities, processes, and process controls in operation
use that have not undergone a formal document validation process. Validation of these facilities,
processes and process controls is possible using historical data to provide the necessary
documentary evidence that the process is doing what it is believed to do.
In each case of retrospective validation, it shall be decided which elements of the above fig.3.2.1.
Shall be used.
In general, the Design Qualification (DQ) shall be left out of the retrospective life cycle and
Requalification will have to be done.
DQ
Revalidation
IQ
Monitoring OQ
Maintenance
Change Control
PQ
In certain circumstances it may not be possible to compete validation programme before routine used. In
These cases it shall be known in advance that the product. Process and equipments shall be used for routine
use.
documents,
the test methods for validation and acceptance criteria for the results are specified, except for the
Validation
be involved.
3.3.1 Design Qualification (DQ): - (Continue...)
1) Protocol: -
Introduction & Protocol Approval
Overview: -
o Objective
o Purpose and scope
o Responsibility
o Qualification team
o Process requirement vs design specification
o Specification provided supplier and given by supplier
o Vendor selection
2) Design qualification report (report shall be prepared as per content provided in IQ-Protocol)
3) Approval procedure
The person responsible from project department shall do the DQ and it shall be reviewed and
checked by person responsible from production and maintenance department respectively.
Finally, design Qualification docket shall be approved by QA Manager.
3.3.2 Installation Qualification (IQ): -
The purpose of the installation qualification is to establish documentary evidence that all parts of
equipment are installed according to the process requirements for the manufacturing in HMA
MEDICAL Limited, Ilorin (Nigeria). It is documented that the operating criteria for the equipment,
as installed are in compliance with the plant functional specifications.
1) Protocol: -
Introduction and protocol approval
Overview: -
o Objective
o Purpose and scope
o Responsibility
o Qualification team
o Description of equipment
o Equipment details
o Design parameters
o Installation checks
o Utility services (if available)
o Procedure
o Acceptance criteria
2) Installation Qualification report (report shall be prepared as per content described in the IQ-
Protocol)
3) Approval procedure
3.3.3 Operational Qualification (OQ): -
The purpose of the operational qualification is to establish documentary evidence that the
equipment and its accessories are capable of operating as per stated ranges and designed criteria.
To start the OQ process for given equipment, it is necessary that the IQ process for same equipment
has been completed. The witness shall be available by signature to ensure that the test procedure
carried out by the operating person is in accordance with their test specifications.
The operational qualification is divided into the following sections:
1) Protocol: -
Introduction and protocol approval
Overview: -
o Objective
o Purpose and scope
o Responsibility
o Qualification team
o Description of equipment/system
o Procedure
o Qualification methodology
o SOPs of operation, calibration, maintenance, training, cleaning etc.
HMA MEDICAL LTD Page 41 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
o Utilities services
o Calibration of measuring instruments
o Acceptance criteria
2) Operational Qualification report (report shall be prepared as per content described in the OQ-
Protocol)
3) Approval procedure
3.3.4 Performance Qualification (PQ): -
The purpose of the performance qualification is to establish documentary evidence that the product
manufacturing by using the equipment shall give consistent quality of product that meets the
predetermined specifications.
The PQ includes critical process parameters and critical quality attributes. To start the PQ process
for given equipment, it is necessary the OQ process for same has been completed. The witness shall
be available by signature to ensure that the operating and test procedure carried out by the operating
person is in accordance with their teat and operating specifications.
All Qualification Procedures for Equipment and Services of the Manufacturing Process Must Be
HMA MEDICAL LTD Page 42 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Process validation protocol shall be prepared before starting of Process validation, covering all
above points. Process validation report shall be prepared as per content described in protocol. After
completion of Checking and Reviewing procedure, Q.A Manager shall state his conclusion in the
document.
3.3.6 Cleaning Validation (CV): -
The purpose of cleaning validation Is to provide documentary evidence that ensures that the cleaning
procedure being used is suitable and delivers consistently, results for cleaning of equipment to
obtain an acceptable level of cleanliness.
No Residue Shall Be Visible, On The Equipment Surface, After Cleaning Procedures Are
HMA MEDICAL LTD Page 43 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Performed.
No More Than the Limit Specified of the Residue Shall Remain, As Residue In Any Equipment,
After Cleaning Procedures Has Been Done. Total Residue of All Equipment Observed in Rinse
Sample Shall Be Less Than the Specified Limit.
Total Residue of All Equipment Observed in Swab Sample Shall Be Less Than the Specified
Limit.
First Batch of the Next Product, Taken After The Cleaning Procedures Are Performed, Shall Pass
Predetermined Specifications.
At Least Three Consecutive Cleaning Runs / Opportunities Shall Meet the Above Mentioned
Acceptance Criteria, Before The Cleaning Procedures Can Be Considered as Validated.
Contents: A detailed discussion of the following points shall be included in validation report
Changes and deviations of the qualification /validation activities from the documentation shall be
listed. The measures taken instead must be justified and incomplete measures must be listed.
Critical points found during qualification/validation shall be listed and the measures taken
described.
The validation report shall include overview of all documentation including annexure.
At the end of the validation report, a conclusion shall be given as to whether or not the equipment
and the process have the status “qualified /validated”.
If it is necessary to edit or remove test specifications from the documentation, this shall be done
according to the following procedure. The version number of the test specification shall be
increased by one after specification is edited.
The changes shall be approved by qualified personnel by signature on a new coversheet. (The approval is
valid for the changes only
4.0 REVALIDATION
The purpose of Revalidation is to maintain the validated status of plan, equipment and manufacturing
process.
The reason for starting of revalidation include:
The transfer of a product from one plant to another: -
For the transfer of a product from one plant to another qualified production plant, it is essential to
revalidate the entire manufacturing process in the new plant. Several new critical or non-critical
parameters must be determined during revalidation.
Revalidation shall be necessary for any of the following reasons:
HMA MEDICAL LTD Page 45 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Assembled
Hub/Cap Moulding Needle Assembling
Assembled Needles Syringes
Q.A.
Verification Check
Q.C. Blister Packing
In-Process Check Q.C.
In-Process Check
Quarantine Product Sterilisation by E.O. gas Packaging of Finished
products
QA Sampling
Water system
Personnel and material flow
Equipment
Material receipt, storage and dispatch
Quality assurance/control testing and inspection
Maintenance and calibration
7.3 Installation Qualification protocols
The installation qualification (IQ) verifies that the equipment or system and/or corresponding
utilities are installed in accordance with design specifications, manufacturer’s recommendations,
and cGMP. The IQ shall confirm that critical instruments are calibrated and that system
components are properly identified. Any exceptions shall be documented, corrected and/or
justified.
Typical installation qualification test functions include, but are not limited to the following:
Manufacturer specification
Purchase order specification
Piping and installation drawing
Construction and installation
Test equipment calibration
Required spare parts
Cleaning
System installation compliance to cGMP
Typical Operational Qualification test functions include, but are not limited to the following:
The Operational Qualification shall be performed in accordance with a reapproved written protocol.
During process validation, three consecutive batches shall be manufactured and all in-process
and finished product specification shall be verified. Critical parameters shall be set at different
ranges during the manufacturing process to verify that the product consistently meets its
predetermined quality specification over the range of critical parameter settings. All equipment
processes, and testing procedures must be validated prior to the start of process validation.
Deviations and/or exceptions to approved protocols, along with suitable explanations and
justifications, shall be documented in the final report.
Deviations and/or exceptions to approved protocols, along with suitable explanations and
justifications, shall be documented in the final report.
A system /equipment/process shall be certified for use in manufacturing upon completion of the
following:
Applicable protocols have been successfully completed and the final report has been approved.
Applicable SOPs have been approved.
Validation shall be completed for all utility systems that support the equipment or process, and
for all equipment that supports a process
All system /equipment/process shall be under calibration criteria
DQ IQ OQ PQ CL FR OP PM CL CA
L
01 √ √ √ √ √ √ √ √ √
02
03
04
HMA MEDICAL LTD Page 54 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
1. Calibration:
2. Preventive maintenance:
The in-charge of the related area and the engineer concerned shall sign the register and verify if
repairs are required.
10.0 KEY STANDARD OPERATING PROCEDURE (SOPs)
List of key procedures for process operations and maintenance are as follows:
Raw material issuing system
Packaging material issuing system
Manufacturing procedures
Batch packing record system
Equipment operating procedures
HMA MEDICAL LTD Page 55 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Acceptance criteria:
The system is constructed and installed in accordance with design specification, manufacturer
recommendations and cGMP.
HMA MEDICAL LTD Page 56 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Acceptance criteria:
Acceptance criteria:
HMA MEDICAL LTD Page 57 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Acceptance criteria:
Flow chart for Syringe and Needle Parts (Barrel, Plunger, Cap and Barrel Printing
Barrel Moulding
Hub) Moulded Barrels
Q.C.
Q.C.
In-Process Check In-Process Check
Printed Barrels
QC Analysis Supplied
Raw Materials
The quality control laboratory serves one of the most critical functions in HMA MEDICAL Ltd.
Consequently, a comprehensive validation program shall be initially performed for procedures
and equipment used for testing of all products, as well as any analytical procedures. Thereafter,
the analytical methods requirements and resulting validation shall be evaluated and performed
as required for each new product.
14.1 Laboratory equipment qualification
Laboratory equipments such as incubators, refrigerators, polar meter, etc. Shall be qualified using the
same approach as that used for process equipment and utility systems.
INSTALLATION QUALIFICATION:
Test functions:
Checks for the fulfilment of the manufacturer’s recommendations (utilities such as electricity,
water and environmental conditions such as humidity, temperature, vibration level and dust)
and allow sufficient shelf space for the equipment, SOPs, operating manuals and software.
Describe vendor selection, instrument design parameter and its capacity in validation docket
Compare equipment, as received, with its purchase order (including software accessories, spare
parts)
Check documentation for completeness (operating manuals, maintenance instructions, standard
operating procedures for testing, safety validation certificates)
Checks equipment for any damages
Switch on the instruments and ensures that all modules power up and perform an electronic
self-test.
Install software on computer following the manufacturer’s/supplier’s recommendation
Verify correct software installation, e.g., are all files loaded. Utilities to do this should be
included in the software itself
Make back up copy of the software and configure peripherals, e.g., printers and equipment
modules
Identify and make a list with a description of all hardware, include drawings where appropriate
List equipment manuals and SOPs
Prepare an installation report
HMA MEDICAL LTD Page 60 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
Acceptance criteria:
OPERATIONAL QUALIFICATION:
Test functions:
Calibrate the parameters like temperature, rpm, gauges, dimension etc.
Check functional parameters of operation
If calibration and functional operation is not satisfactory, get it rectified from the engineer and
recheck the instrument
If calibration and functional operation is satisfactory, proceed for performance qualification.
Acceptance criteria:
The system should operate as per testing requirement
Calibration and function operation must give satisfactory result
PERFORMANCE QUALIFICATION:
Test function:
Carryout the performance of instrument as per standard calibration procedure of the respective
instrument
Measure performance characteristic of instrument and compare with the document preset limit
If performance is satisfactory, instrument may be released for use
If performance is not satisfactory, call service engineer/vendor for necessary corrective actions
Record all the result and get approved
All the documents like purchase order, supplier’s validation certificates, list of manuals etc., to
be attached with the report of performance qualification
Acceptance criteria:
CALIBRATION:
Each equipment of quality control should undergo calibration program
Each equipment should be calibrated before use
HMA MEDICAL LTD Page 61 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
METHOD VALIDATION:
Each analytical method should be validated before use
Method validation should contain following performance parameters.
Precision
Accuracy
Selectivity & specificity
Limit of detection
Limits of quantification
Linearity and range
Ruggedness or robustness
Stability of analytical solution
Check following parameters during quantitative analysis of active ingredients and finished
product
Accuracy
Precision
Specificity
Linearity
Range
Check following parameters during quantitative analysis of impurities in RM & finished
products
Accuracy
Precision
Specificity
Check following parameters during quantitative analysis of finished products before cleaning
validation.
Blank interference
Stability of analytical solution
Linearity
Range
Limit of quantification
Limit of detection
CLEANING VALIDATION:
HMA MEDICAL LTD Page 62 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil
D IQ O P C CL PQ O CAL
Q Q Q L P
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
HMA MEDICAL LTD Page 64 of 64
Plot 9, Block 4, Transit Camp Road, Ilorin, Kwara State, Nigeria.
ESTABLISHMENT DOCUMENT
Title: Validation Master Plan
Department: Quality Assurance Issued Date: 6th June, 2023
Mandatory Review Date: 12th June, 2025 Effective Date: 13th June, 2023
SOP NO: HMA/QAD/VMP001-00 Supersede: Nil